Följ
Charles Jeffrey Smith
Charles Jeffrey Smith
Verifierad e-postadress på health.missouri.edu
Titel
Citeras av
Citeras av
År
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity
N Chanda, V Kattumuri, R Shukla, A Zambre, K Katti, A Upendran, ...
Proceedings of the National Academy of Sciences 107 (19), 8760-8765, 2010
3722010
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice
N Chanda, P Kan, LD Watkinson, R Shukla, A Zambre, TL Carmack, ...
Nanomedicine in Cancer, 753-774, 2017
2832017
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer
R Shukla, N Chanda, A Zambre, A Upendran, K Katti, RR Kulkarni, ...
Proceedings of the National Academy of Sciences 109 (31), 12426-12431, 2012
2802012
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes
CJ Smith, WA Volkert, TJ Hoffman
Nuclear medicine and biology 32 (7), 733-740, 2005
2602005
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
AF Prasanphanich, PK Nanda, TL Rold, L Ma, MR Lewis, JC Garrison, ...
Proceedings of the National Academy of Sciences 104 (30), 12462-12467, 2007
2592007
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate …
TJ Hoffman, H Gali, CJ Smith, GL Sieckman, DL Hayes, NK Owen, ...
Journal of Nuclear Medicine 44 (5), 823-831, 2003
2132003
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update
CJ Smith, WA Volkert, TJ Hoffman
Nuclear medicine and biology 30 (8), 861-868, 2003
1852003
Design and development of functionalized water-soluble phosphines: catalytic and biomedical implications
KV Katti, H Gali, CJ Smith, DE Berning
Accounts of chemical research 32 (1), 9-17, 1999
1661999
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN [7-14] NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate …
CJ Smith, H Gali, GL Sieckman, DL Hayes, NK Owen, DG Mazuru, ...
Nuclear medicine and biology 30 (2), 101-109, 2003
1622003
Radiochemical Investigations of 99mTc−N3S-X-BBN[7−14]NH2:  An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon …
CJ Smith, H Gali, GL Sieckman, C Higginbotham, WA Volkert, TJ Hoffman
Bioconjugate chemistry 14 (1), 93-102, 2003
1532003
Radiochemical investigations of gastrin-releasing peptide receptor-specific [99mTc (X)(CO) 3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing …
CJ Smith, GL Sieckman, NK Owen, DL Hayes, DG Mazuru, R Kannan, ...
Cancer research 63 (14), 4082-4088, 2003
1422003
Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles
R Kannan, V Rahing, C Cutler, R Pandrapragada, KK Katti, V Kattumuri, ...
Journal of the American Chemical Society 128 (35), 11342-11343, 2006
1292006
Current and potential therapeutic uses of lanthanide radioisotopes
CS Cutler, CJ Smith, GJ Ehrhardt, TT Tyler, SS Jurisson, E Deutsch
Cancer biotherapy & radiopharmaceuticals 15 (6), 531-545, 2000
1232000
Pyrazolyl Derivatives as Bifunctional Chelators for Labeling Tumor-Seeking Peptides with the fac-[M(CO)3]+ Moiety (M = 99mTc, Re):  Synthesis …
S Alves, A Paulo, JDG Correia, L Gano, CJ Smith, TJ Hoffman, I Santos
Bioconjugate chemistry 16 (2), 438-449, 2005
1012005
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies
BL Faintuch, R Teodoro, A Duatti, E Muramoto, S Faintuch, CJ Smith
Nuclear medicine and biology 35 (4), 401-411, 2008
1002008
Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin
ME Moustapha, GJ Ehrhardt, CJ Smith, LP Szajek, WC Eckelman, ...
Nuclear medicine and biology 33 (1), 81-89, 2006
992006
Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists,[64Cu-NO2A-(X)-BBN (7–14) NH2], in a prostate tumor xenografted mouse model
SR Lane, P Nanda, TL Rold, GL Sieckman, SD Figueroa, TJ Hoffman, ...
Nuclear medicine and biology 37 (7), 751-761, 2010
982010
In Vitro and In Vivo Evaluation of a Novel 99mTc(CO)3-Pyrazolyl Conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys)
S Alves, JDG Correia, L Gano, TL Rold, A Prasanphanich, R Haubner, ...
Bioconjugate chemistry 18 (2), 530-537, 2007
962007
Comparison of in vitro and in vivo properties of [99mTc] cRGD peptides labeled using different novel Tc-cores
C Decristoforo, I Santos, HJ Pietzsch, JU Kuenstler, A Duatti, CJ Smith, ...
QJ Nucl Med Mol Imaging 51 (1), 33-41, 2007
942007
In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN (7–14) NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors
AF Prasanphanich, L Retzloff, SR Lane, PK Nanda, GL Sieckman, ...
Nuclear medicine and biology 36 (2), 171-181, 2009
882009
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20